TGF-β2–Mediated Ocular Hypertension Is Attenuated in SPARC-Null Mice-Reference-Cited by-同舟云学术

TGF-β2–Mediated Ocular Hypertension Is Attenuated in SPARC-Null Mice

Published:2014-07-01 Issue:7 Volume:55 Page:4084
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Swaminathan Swarup S.¹,Oh Dong-Jin¹,Kang Min Hyung¹,Shepard Allan R.²,Pang Iok-Hou³,Rhee Douglas J.¹

Affiliation:

1. Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, United States

2. Ophthalmology Research/Glaucoma Research, Novartis Institutes for Biomedical Research, Fort Worth, Texas, United States

3. Department of Pharmaceutical Sciences and North Texas Eye Research Institute, University of North Texas Health Sciences Center, Fort Worth, Texas, United States

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protective effect of the natural flavonoid naringenin in mouse models of retinal injury;European Journal of Pharmacology;2024-01

2. Genetic rodent models of glaucoma in representing disease phenotype and insights into the pathogenesis;Molecular Aspects of Medicine;2023-12

3. Roles of four targets in the pathogenesis of graves' orbitopathy;Heliyon;2023-09

4. SPARC-YAP/TAZ inhibition prevents the fibroblasts-myofibroblasts transformation;Experimental Cell Research;2023-08

5. SPARC: a potential target for functional nanomaterials and drugs;Frontiers in Molecular Biosciences;2023-07-28